Answers are grounded in this paper and cite their sources.
Berberine is a quaternary benzylisoquinoline alkaloid found in various medicinal plants, including species of Coptis, Phellodendron, and Berberis. Berberine exerts anti-inflammatory effects and lowers blood glucose, cholesterol, and triglyceride levels, suggesting its potential for preventing lifestyle-related diseases. This study investigated the effects of 23 berberine derivatives on adipocyte differentiation and lipid accumulation in 3T3-L1 cells. At 1 μM, several berberine derivatives markedly inhibited lipid accumulation during adipocyte differentiation without affecting cell viability, and seven of these derivatives demonstrated inhibitory activity comparable to that observed with 4 μM berberine. Notably, 13-ethylberberine iodide (1), 13-allylberberine bromide (9), and 8-n-butylberberine bromide (19) exhibited dose-dependent inhibitory effects. These derivatives (1, 9, and 19) significantly suppressed the expression of adipocyte marker genes, including peroxisome proliferator-activated receptor γ2 (Pparγ2), CCAAT/enhancer binding protein α, and adipocyte fatty acid binding protein. Further analysis revealed that these derivatives reduced early differentiation-associated cell proliferation, Pparγ2 expression, and PPARγ2 transcriptional activity. Thus, these derivatives may represent promising candidates for developing agents that modulate adipocyte differentiation and lipid accumulation.
No takes yet. Share an insight, caveat, or question.
Nobushi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: